SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:1460 2105 "

Sökning: L773:1460 2105

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Abou, Diane S, et al. (författare)
  • Whole-Body and Microenvironmental Localization of Radium-223 in Naïve and Mouse Models of Prostate Cancer Metastasis.
  • 2016
  • Ingår i: Journal of the National Cancer Institute. - Oxford University Press. - 1460-2105. ; 108:5
  • Tidskriftsartikel (refereegranskat)abstract
    • Bone-metastatic, castration-resistant prostate cancer (bmCRPC) represents a lethal stage of the most common noncutaneous cancer in men. The recent introduction of Radium-223 dichloride, a bone-seeking alpha particle (α)-emitting radiopharmaceutical, demonstrates statistically significant survival benefit and palliative effect for bmCRPC patients. Clinical results have established safety and efficacy, yet questions remain regarding pharmacodynamics and dosing for optimized patient benefit.
  •  
2.
  •  
3.
  •  
4.
  • Akre, O, et al. (författare)
  • Body size and testicular cancer
  • 2000
  • Ingår i: Journal of the National Cancer Institute. - 0027-8874 .- 1460-2105. ; 92:13, s. 1093-1096
  • Tidskriftsartikel (refereegranskat)
  •  
5.
  •  
6.
  • Aleksandrova, Krasimira, et al. (författare)
  • A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk
  • 2015
  • Ingår i: Journal of the National Cancer Institute. - Oxford University Press. - 0027-8874 .- 1460-2105. ; 107:4
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Background: Neopterin may be relevant for colorectal cancer (CRC) development, as a biomarker of cellular immune activity exerting pleiotropic effects on cellular ageing, oxidative stress, and inflammation. So far, the association between prediagnostic neopterin and colon and rectal cancer risk has not been evaluated in human populations. Methods: A nested case-control study was conducted within the European Prospective Investigation into Cancer and Nutrition cohort using data on plasma concentrations of total neopterin (T-N, sum of neopterin and 7,8-dihydroneopterin) in 830 incident CRC case patients (561 colon and 269 rectal) matched within risk sets to 830 control participants. A subsequent replication study used data from the Hordaland Health Study, where 173 CRC case patients have been diagnosed among 6594 healthy participants over 12 years of follow-up. Results: After multivariable adjustment for a priori chosen CRC risk factors, a "U-shaped" association of T-N with CRC was revealed. Compared with the second quintile of the T-N distribution, the relative risks for the first, third, fourth, and fifth quintiles were 2.37 (95% CI = 1.66 to 3.39), 1.24 (95% CI = 0.87 to 1.77), 1.55 (95% CI = 1.08 to 2.22), and 2.31 (95% CI = 1.63 to 3.27), respectively. Replication of these associations within the Hordaland Health Study yielded similar results. No differences have been observed when the associations were explored by colon and rectal cancer site (two-sided P-difference = .87) and after excluding case patients diagnosed within the first four follow-up years. Conclusions: These novel findings provide evidence of the role of both suppressed and activated cell-mediated immunity as reflected by prediagnostic T-N concentrations in the development of CRC.</p>
  •  
7.
  • Allen, Naomi E., et al. (författare)
  • Selenium and Prostate Cancer Analysis of Individual Participant Data From Fifteen Prospective Studies
  • 2016
  • Ingår i: Journal of the National Cancer Institute. - 0027-8874 .- 1460-2105. ; 108:11
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Background: Some observational studies suggest that a higher selenium status is associated with a lower risk of prostate cancer but have been generally too small to provide precise estimates of associations, particularly by disease stage and grade. Methods: Collaborating investigators from 15 prospective studies provided individual-participant records (from predominantly men of white European ancestry) on blood or toenail selenium concentrations and prostate cancer risk. Odds ratios of prostate cancer by selenium concentration were estimated using multivariable-adjusted conditional logistic regression. All statistical tests were two-sided. Results: Blood selenium was not associated with the risk of total prostate cancer (multivariable-adjusted odds ratio [OR] per 80 percentile increase = 1.01, 95% confidence interval [CI] = 0.83 to 1.23, based on 4527 case patients and 6021 control subjects). However, there was heterogeneity by disease aggressiveness (ie, advanced stage and/or prostate cancer death, P-heterogeneity = .01), with high blood selenium associated with a lower risk of aggressive disease (OR = 0.43, 95% CI = 0.21 to 0.87) but not with nonaggressive disease. Nail selenium was inversely associated with total prostate cancer (OR = 0.29, 95% CI = 0.22 to 0.40, P-trend &lt;.001, based on 1970 case patients and 2086 control subjects), including both nonaggressive (OR = 0.33, 95% CI = 0.22 to 0.50) and aggressive disease (OR = 0.18, 95% CI = 0.11 to 0.31, P-heterogeneity =.08). Conclusions: Nail, but not blood, selenium concentration is inversely associated with risk of total prostate cancer, possibly because nails are a more reliable marker of long-term selenium exposure. Both blood and nail selenium concentrations are associated with a reduced risk of aggressive disease, which warrants further investigation.</p>
  •  
8.
  • Allen, Naomi E, et al. (författare)
  • Selenium and Prostate Cancer : Analysis of Individual Participant Data From Fifteen Prospective Studies.
  • 2016
  • Ingår i: Journal of the National Cancer Institute. - 0027-8874 .- 1460-2105. ; 108:11
  • Tidskriftsartikel (refereegranskat)abstract
    • <p><strong>BACKGROUND:</strong> Some observational studies suggest that a higher selenium status is associated with a lower risk of prostate cancer but have been generally too small to provide precise estimates of associations, particularly by disease stage and grade.</p><p><strong>METHODS:</strong> Collaborating investigators from 15 prospective studies provided individual-participant records (from predominantly men of white European ancestry) on blood or toenail selenium concentrations and prostate cancer risk. Odds ratios of prostate cancer by selenium concentration were estimated using multivariable-adjusted conditional logistic regression. All statistical tests were two-sided.</p><p><strong>RESULTS:</strong> Blood selenium was not associated with the risk of total prostate cancer (multivariable-adjusted odds ratio [OR] per 80 percentile increase = 1.01, 95% confidence interval [CI] = 0.83 to 1.23, based on 4527 case patients and 6021 control subjects). However, there was heterogeneity by disease aggressiveness (ie, advanced stage and/or prostate cancer death, Pheterogeneity = .01), with high blood selenium associated with a lower risk of aggressive disease (OR = 0.43, 95% CI = 0.21 to 0.87) but not with nonaggressive disease. Nail selenium was inversely associated with total prostate cancer (OR = 0.29, 95% CI = 0.22 to 0.40, Ptrend &lt; .001, based on 1970 case patients and 2086 control subjects), including both nonaggressive (OR = 0.33, 95% CI = 0.22 to 0.50) and aggressive disease (OR = 0.18, 95% CI = 0.11 to 0.31, Pheterogeneity = .08).</p><p><strong>CONCLUSIONS:</strong> Nail, but not blood, selenium concentration is inversely associated with risk of total prostate cancer, possibly because nails are a more reliable marker of long-term selenium exposure. Both blood and nail selenium concentrations are associated with a reduced risk of aggressive disease, which warrants further investigation.</p>
  •  
9.
  • Andrae, Bengt, et al. (författare)
  • Screening-preventable cervical cancer risks: Evidence from a nationwide audit in Sweden
  • 2008
  • Ingår i: Journal of the National Cancer Institute. - Oxford University Press. - 1460-2105. ; 100:9, s. 622-629
  • Tidskriftsartikel (refereegranskat)abstract
    • Background The effectiveness of cervical cancer screening programs differs widely in different populations. The reasons for these differences are unclear. Routine and comprehensive audits have been proposed as an ethically required component of screening. We performed a nationwide audit of the effectiveness of the Swedish cervical cancer screening program. Methods We identified all invasive cervical cancer cases that were diagnosed in Sweden from January 1, 1999, through December 31, 2001, and had been reported to the Swedish Cancer Registry (n = 1230 cases). We verified the diagnoses by histopathologic rereview and matched each case subject to five (population-based) age-matched control subjects who were identified from the National Population Register. The Pap smear screening histories for case and control subjects were reviewed for a 6-year period using the National Cervical Cancer Screening Register, which contains data on essentially all relevant cytological and histological diagnoses in Sweden. Odds ratios (ORs), and their 95% confidence intervals (CIs), of cervical cancer according to screening history were calculated in conditional logistic regression models. All statistical tests were two-sided. Results Women who had not had a Pap smear within the recommended screening interval had higher risk of cervical cancer than women who had been screened (OR = 2.52, 95% CI = 2.19 to 2.91). This risk was similarly increased for all age groups (P-homogeneity = .96). The risk for nonsquamous cell cervical cancers (OR = 1.59, 95% CI = 1.20 to 2.11) was also increased. Women who had not had a Pap smear within the recommended screening interval had a particularly high risk of advanced cancers (OR = 4.82, 95% CI = 3.61 to 6.44). Among women who had been screened within the recommended interval, those with abnormal Pap smears had a higher risk of cervical cancer than those with normal smears (OR = 7.55, 95% CI = 5.88 to 9.69) and constituted 11.5% of all women with cervical cancer. Conclusions Nonadherence to screening intervals was the major reason for cervical cancer morbidity. The screening program was equally effective for women of all ages and was also effective against nonsquamous cancers.
10.
  • Andrae, Bengt, et al. (författare)
  • Screening-preventable cervical cancer risks : evidence from a nationwide audit in Sweden.
  • 2008
  • Ingår i: J Natl Cancer Inst. - 1460-2105. ; 100:9, s. 622-9
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Background: The effectiveness of cervical cancer screening programs differs widely in different populations. The reasons for these differences are unclear. Routine and comprehensive audits have been proposed as an ethically required component of screening. We performed a nationwide audit of the effectiveness of the Swedish cervical cancer screening program.</p><p>Methods: We identified all invasive cervical cancer cases that were diagnosed in Sweden from January 1, 1999, through December 31, 2001, and had been reported to the Swedish Cancer Registry (n = 1230 cases). We verified the diagnoses by histopathologic rereview and matched each case subject to five (population-based) age-matched control subjects who were identified from the National Population Register. The Pap smear screening histories for case and control subjects were reviewed for a 6-year period using the National Cervical Cancer Screening Register, which contains data on essentially all relevant cytological and histological diagnoses in Sweden. Odds ratios (ORs), and their 95% confidence intervals (CIs), of cervical cancer according to screening history were calculated in conditional logistic regression models. All statistical tests were two-sided.</p><p>Results: Women who had not had a Pap smear within the recommended screening interval had higher risk of cervical cancer than women who had been screened (OR = 2.52, 95% CI = 2.19 to 2.91). This risk was similarly increased for all age groups (Phomogeneity = .96). The risk for nonsquamous cell cervical cancers (OR = 1.59, 95% CI = 1.20 to 2.11) was also increased. Women who had not had a Pap smear within the recommended screening interval had a particularly high risk of advanced cancers (OR = 4.82, 95% CI = 3.61 to 6.44). Among women who had been screened within the recommended interval, those with abnormal Pap smears had a higher risk of cervical cancer than those with normal smears (OR = 7.55, 95% CI = 5.88 to 9.69) and constituted 11.5% of all women with cervical cancer.</p><p>Conclusions: Nonadherence to screening intervals was the major reason for cervical cancer morbidity. The screening program was equally effective for women of all ages and was also effective against nonsquamous cancers.</p>
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (50)
Typ av publikation
tidskriftsartikel (320)
forskningsöversikt (2)
recension (1)
Typ av innehåll
refereegranskat (300)
övrigt vetenskapligt (34)
Författare/redaktör
Adami, Hans Olov (29)
Bueno-de-Mesquita, H ... (26)
Trichopoulou, Antoni ... (25)
Riboli, Elio (25)
Adami, HO, (25)
Palli, Domenico (23)
visa fler...
Trichopoulos, Dimitr ... (22)
Kaaks, Rudolf (21)
Boeing, Heiner (21)
Khaw, Kay-Tee (21)
Stattin, Pär, (20)
Wolk, A, (20)
Panico, Salvatore (20)
Glimelius, Bengt, (18)
Tumino, Rosario (18)
Peeters, Petra H M (18)
Weiderpass, E, (17)
Overvad, Kim (17)
Boutron-Ruault, Mari ... (17)
Travis, Ruth C (17)
Clavel-Chapelon, Fra ... (16)
Hall, P, (16)
Dorronsoro, Miren (16)
Holmberg, Lars, (15)
Tjonneland, Anne (14)
Giles, GG (14)
Weiderpass, Elisabet ... (14)
Gronberg, H, (14)
Vineis, Paolo (14)
Lund, Eiliv (13)
Tjønneland, Anne (13)
Czene, K, (13)
Olsson, Håkan, (13)
Jenab, Mazda (13)
Boffetta, Paolo (13)
Larsson, SC, (13)
Sanchez, Maria-Jose (12)
Kaaks, R (12)
Riboli, E (12)
Johansson, Jan-Erik (12)
Melbye, Mads (12)
Navarro, Carmen (12)
Hallmans, Göran (12)
Tjonneland, A (11)
Linseisen, Jakob (11)
Barricarte, Aurelio (11)
Melbye, M (11)
Chang-Claude, J (11)
Gonzalez, Carlos A. (11)
Hunter, DJ (11)
visa färre...
Lärosäte
Karolinska Institutet (158)
Lunds universitet (67)
Umeå universitet (49)
Uppsala universitet (45)
Göteborgs universitet (12)
Linköpings universitet (11)
visa fler...
Örebro universitet (7)
Mälardalens högskola (5)
Stockholms universitet (2)
Södertörns högskola (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (321)
Odefinierat språk (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (173)
Lantbruksvetenskap (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy